Rotator Cuff SyndromeNCT07645963
Effects of Myofascial Trigger Point Release Versus Neil Asher Technique Oin Patients With Rotator Cuff Syndrome
A study testing Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group and Neil Asher Technique (NAT) + conservative physiotherapy Group in people with Rotator Cuff Syndrome, run by Riphah International University at 1 site in Pakistan.
Trial summary
Rotator cuff syndrome is a common cause of shoulder pain and functional limitation, often associated with myofascial trigger points. Myofascial Trigger Point Release (MFTR) and the Neil Asher Technique (NAT) are manual therapies aimed at reducing pain and improving mobility. Read more about this study
- Who is it for?
- Ages 40 to 60 years
- Conditions the study is for
- Rotator Cuff Syndrome
- What is being tested?
- Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group and Neil Asher Technique (NAT) + conservative physiotherapy Group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 sitePakistan
- Study dates
- 30 Jun 2026to 30 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age 40-60 years
- Positive Neer's and Hawkins Kennedy test (27)
- Grade 1 or 2 rotator cuff syndrome (non-surgical)
Who cannot join
- Cardiac issues (e.g., myocardial infarction)
- Fibromyalgia
- Pregnancy
- Trauma-related shoulder pain
- History of shoulder surgery
- Numbness, tingling
- Corticosteroid injections
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site
University of Lahore Teaching Hospital, Lahore HOD Physio Department
Lahore, Punjab Province, 54000
About this study
Official title: Effects of Myofascial Trigger Point Release Versus Neil Asher Technique on Pain, Range of Motion, and Disability in Patients With Rotator Cuff Syndrome
Rotator cuff syndrome is a common cause of shoulder pain and functional limitation, often associated with myofascial trigger points. Myofascial Trigger Point Release (MFTR) and the Neil Asher Technique (NAT) are manual therapies aimed at reducing pain and improving mobility. This study compares their effects on pain, range of motion, and disability in individuals with rotator cuff syndrome.
Read the detailed description
This will be a randomized Clinical trial conducted on 36 participants. Data will be collected from Jinnah hospital and The University of Lahore Teaching Hospital, Lahore by using non-probability convenience sampling technique. Adults aged 40 to 60 years with non-surgical rotator cuff-related shoulder pain, confirmed by positive Neer's or Hawkins-Kennedy tests and experiencing symptoms for more than four weeks, will be included in this study. Individuals with cardiac conditions, pregnancy, trauma-related shoulder injuries, or a history of shoulder surgery will be excluded. Group A will receive Myofascial Trigger Point Release (MFTR) along with conservative physiotherapy, while Group B will receive the Neil Asher Technique (NAT) combined with conservative physiotherapy. Each session will last 35 minutes-20 minutes for the primary intervention and 15 minutes for conventional therapy-administered four times per week for four weeks. Pre- and post-treatment evaluations will include the Numeric Pain Rating Scale (NPRS), range of motion (using a Universal Goniometer), and disability (measured via SPADI). Data will be analyzed using SPSS version 27.0.
- Conditions
- Rotator Cuff Syndrome
- Being tested
- Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group, Neil Asher Technique (NAT) + conservative physiotherapy Group
- Keywords
- pain, functional disability, range of motion
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy GroupOther
lateral border of the scapula, just below the infraspinatus.
- Compression is followed by horizontal abduction and external rotation to stretch the muscle.
Ischemic Compression: Each active trigger point is treated with 2 sets of deep pressure, applied using the therapist's fingers, thumb, or elbow.
Duration: Each compression lasts 20-30 seconds, gradually increasing pressure to the patient's tolerance.
Post-Compression Stretching: Gentle passive stretching of the treated muscle follows immediately after each compression set to restore muscle length.
Each session will last 35 minutes (5 minutes hot pack, 10 minutes stretching, 20 minutes Myofascial Trigger Point Release)
Neil Asher Technique (NAT) + conservative physiotherapy GroupOther
The NAT is a non-invasive trigger point therapy that applies a specific sequence of ischemic compressions to deactivate active trigger points, stimulate reflex responses, and promote muscular balance.
Apply several deep strokes over the fibrous band and then each trigger point is treated with sustained manual pressure for 20-30 seconds, repeated 2-3 times per session.
Hot Pack Application: A moist hot pack will be applied over the affected shoulder for 5 minutes using a protective towel.
Shoulder Stretching Routine: Includes flexion/extension, abduction/adduction, and internal/external rotation (each stretch held for 20-30 seconds and repeated 3-5 times).
| Study group | Role | What they receive |
|---|---|---|
| Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group) | Experimental | This group will be given Myofascial Trigger Point Release (MFTR) with basic physiotherapy care. Receives: Other: Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group |
| Neil Asher Technique (NAT) + conservative physiotherapy Group | Active comparator | This group will be given Neil Asher Technique (NAT) along with basic physiotherapy care. Receives: Other: Neil Asher Technique (NAT) + conservative physiotherapy Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Numeric Pain Rating Scale (NPRS) - Pain Assessment
The Numeric Pain Rating Scale (NPRS) is a unidimensional, patient-reported outcome measure used to assess pain intensity. Participants are asked to rate their current pain level, or average pain over a specified recall period (e.g., past 24 hours or past week), using an 11-point scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain."
Measured: upto 4 weeks
Universal Goniometer (UG) - Range of Motion (ROM)
The Universal Goniometer (UG) is a standard clinical instrument used for measuring joint range of motion (ROM) in degrees. It consists of a fulcrum, stationary arm, and movable arm, allowing precise angular measurement of joint movement.
For ROM assessment, the participant is positioned according to standardized protocols (supine, prone, or sitting depending on the joint being assessed). Anatomical landmarks are used for alignment to ensure accuracy and reliability. The stationary arm is aligned with the proximal segment of the joint, while the movable arm follows the distal segment.
Measured: upto 4 weeks
Shoulder Pain and Disability Index (SPADI) - Disability Outcome
The Shoulder Pain and Disability Index (SPADI) is a validated, self-administered questionnaire designed to measure pain and functional disability in patients with shoulder conditions.
It consists of 13 items divided into two subscales:
Pain subscale (5 items) - assesses severity of shoulder pain during specific activities Disability subscale (8 items) - assesses difficulty in performing functional tasks such as dressing, reaching, lifting, and carrying objects
Each item is scored on a Visual Analog Scale (0-10), where higher scores indicate greater pain and disability. The total SPADI score is calculated as a percentage, with 0% representing no disability and 100% representing maximum disability.
Measured: upto 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2026
- Study start30 Jun 2026 (estimated)
- Primary completion30 Sep 2026 (estimated)
- Study completion30 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for Rotator Cuff SyndromeStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Iqra Nazir, MSPT*, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07645963
- Sponsor's protocol ID
- REC/RCR&AHS/25/0116 Iqra
- Status last verified
- Jun 2026
- First submitted
- 8 Jun 2026
- Last updated
- 12 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Varacallo MA, El Bitar Y, Sina RE, Mair SD. Rotator Cuff Syndrome. 2024 Mar 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK531506/
PubMed 30285401Kuhn JE. Prevalence, natural history, and nonoperative treatment of rotator cuff disease. Operative techniques in sports medicine. 2023;31(1):150978.
Meyers AR, Wurzelbacher SJ, Krieg EF, Ramsey JG, Crombie K, Christianson AL, Luo L, Burt S. Work-Related Risk Factors for Rotator Cuff Syndrome in a Prospective Study of Manufacturing and Healthcare Workers. Hum Factors. 2023 May;65(3):419-434. doi: 10.1177/00187208211022122. Epub 2021 Jun 20.
PubMed 34148475Zahra T, Altaf F, Akhtar H, Awan SS, Sher UA, Waris S. Sleep Quality and Nocturnal Pain in Patients of Rotator Cuff Syndrome. Pakistan Journal of Medical & Health Sciences. 2022;16(09):394-.
Kwan CK, Ko MC, Fu SC, Leong HT, Ling SK, Oh JH, Yung PS. Are muscle weakness and stiffness risk factors of the development of rotator cuff tendinopathy in overhead athletes: a systematic review. Ther Adv Chronic Dis. 2021 Jul 3;12:20406223211026178. doi: 10.1177/20406223211026178. eCollection 2021.
PubMed 34276924Sidiropoulos K, Samundeeswari S, Giannatos V, Kotsapas M, Arrigoni P, Montoya F, Brilakis E, Latz D, Koukos C. Partial Cuff Repair in Rotator Cuff Tears: Current Concepts and Clinical Considerations. Indian J Orthop. 2025 Feb 4;59(6):743-755. doi: 10.1007/s43465-025-01338-0. eCollection 2025 Jun.
PubMed 40511351Zhao J, Luo M, Pan J, Liang G, Feng W, Zeng L, Yang W, Liu J. Risk factors affecting rotator cuff retear after arthroscopic repair: a meta-analysis and systematic review. J Shoulder Elbow Surg. 2021 Nov;30(11):2660-2670. doi: 10.1016/j.jse.2021.05.010. Epub 2021 Jun 2.
PubMed 34089878Giri A, O'Hanlon D, Jain NB. Risk factors for rotator cuff disease: A systematic review and meta-analysis of diabetes, hypertension, and hyperlipidemia. Ann Phys Rehabil Med. 2023 Feb;66(1):101631. doi: 10.1016/j.rehab.2022.101631. Epub 2022 Nov 30.
PubMed 35257948Khadour FA, Khadour YA, Alharbi NSK, Alhatem W, Albarroush D, Dao X. Risk factors for rotator cuff tear in Syrian adults: a cross-sectional study. Sci Rep. 2025 Feb 18;15(1):5837. doi: 10.1038/s41598-025-89878-1.
PubMed 39966503Javed O, Maldonado KA, Ashmyan R. Anatomy, Shoulder and Upper Limb, Muscles. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK482410/
PubMed 29494017Cao Z, Li Q, Li Y, Wu J. The association of metabolic syndrome with rotator cuff tendinopathy: a two-sample Mendelian randomization study. Diabetol Metab Syndr. 2023 Oct 24;15(1):211. doi: 10.1186/s13098-023-01189-5.
PubMed 37875953
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Myofascial Trigger Point Release Versus Neil Asher Technique on Pain, Range of Motion, and Disability in Patients With Rotator Cuff Syndrome
- ClinicalTrials.gov ID
- NCT07645963
- Acronym / sponsor ID
- REC/RCR&AHS/25/0116 Iqra
- Conditions
- Rotator Cuff Syndrome
- Keywords
- pain, functional disability, range of motion
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 30 Jun 2026 (estimated)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 30 Oct 2026 (estimated)
- First posted
- 12 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Rotator cuff syndrome is a common cause of shoulder pain and functional limitation, often associated with myofascial trigger points. Myofascial Trigger Point Release (MFTR) and the Neil Asher Technique (NAT) are manual therapies aimed at reducing pain and improving mobility. This study compares their effects on pain, range of motion, and disability in individuals with rotator cuff syndrome.
Detailed description
This will be a randomized Clinical trial conducted on 36 participants. Data will be collected from Jinnah hospital and The University of Lahore Teaching Hospital, Lahore by using non-probability convenience sampling technique. Adults aged 40 to 60 years with non-surgical rotator cuff-related shoulder pain, confirmed by positive Neer's or Hawkins-Kennedy tests and experiencing symptoms for more than four weeks, will be included in this study. Individuals with cardiac conditions, pregnancy, trauma-related shoulder injuries, or a history of shoulder surgery will be excluded. Group A will receive Myofascial Trigger Point Release (MFTR) along with conservative physiotherapy, while Group B will receive the Neil Asher Technique (NAT) combined with conservative physiotherapy. Each session will last 35 minutes-20 minutes for the primary intervention and 15 minutes for conventional therapy-administered four times per week for four weeks. Pre- and post-treatment evaluations will include the Numeric Pain Rating Scale (NPRS), range of motion (using a Universal Goniometer), and disability (measured via SPADI). Data will be analyzed using SPSS version 27.0.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group) | Experimental | Other: Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy GroupThis group will be given Myofascial Trigger Point Release (MFTR) with basic physiotherapy care. |
| Neil Asher Technique (NAT) + conservative physiotherapy Group | Active comparator | Other: Neil Asher Technique (NAT) + conservative physiotherapy GroupThis group will be given Neil Asher Technique (NAT) along with basic physiotherapy care. |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Age 40-60 years
- Positive Neer's and Hawkins Kennedy test (27)
- Grade 1 or 2 rotator cuff syndrome (non-surgical)
Key exclusion criteria (7 listed)
- Cardiac issues (e.g., myocardial infarction)
- Fibromyalgia
- Pregnancy
- Trauma-related shoulder pain
- History of shoulder surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Grouplateral border of the scapula, just below the infraspinatus. • Compression is followed by horizontal abduction and external rotation to stretch the muscle. Ischemic Compression: Each active trigger point is treated with 2 sets of deep pressure, applied using the therapist's fingers, thumb, or elbow. Duration: Each compression lasts 20-30 seconds, gradually increasing pressure to the patient's tolerance. Post-Compression Stretching: Gentle passive stretching of the treated muscle follows immediately after each compression set to restore muscle length. Each session will last 35 minutes (5 minutes hot pack, 10 minutes stretching, 20 minutes Myofascial Trigger Point Release) | Other | Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group) |
| Neil Asher Technique (NAT) + conservative physiotherapy GroupThe NAT is a non-invasive trigger point therapy that applies a specific sequence of ischemic compressions to deactivate active trigger points, stimulate reflex responses, and promote muscular balance. Apply several deep strokes over the fibrous band and then each trigger point is treated with sustained manual pressure for 20-30 seconds, repeated 2-3 times per session. Hot Pack Application: A moist hot pack will be applied over the affected shoulder for 5 minutes using a protective towel. Shoulder Stretching Routine: Includes flexion/extension, abduction/adduction, and internal/external rotation (each stretch held for 20-30 seconds and repeated 3-5 times). | Other | Neil Asher Technique (NAT) + conservative physiotherapy Group |
Primary outcome
Numeric Pain Rating Scale (NPRS) - Pain Assessment
Time frame: upto 4 weeks
The Numeric Pain Rating Scale (NPRS) is a unidimensional, patient-reported outcome measure used to assess pain intensity. Participants are asked to rate their current pain level, or average pain over a specified recall period (e.g., past 24 hours or past week), using an 11-point scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain."
Universal Goniometer (UG) - Range of Motion (ROM)
Time frame: upto 4 weeks
The Universal Goniometer (UG) is a standard clinical instrument used for measuring joint range of motion (ROM) in degrees. It consists of a fulcrum, stationary arm, and movable arm, allowing precise angular measurement of joint movement. For ROM assessment, the participant is positioned according to standardized protocols (supine, prone, or sitting depending on the joint being assessed). Anatomical landmarks are used for alignment to ensure accuracy and reliability. The stationary arm is aligned with the proximal segment of the joint, while the movable arm follows the distal segment.
Shoulder Pain and Disability Index (SPADI) - Disability Outcome
Time frame: upto 4 weeks
The Shoulder Pain and Disability Index (SPADI) is a validated, self-administered questionnaire designed to measure pain and functional disability in patients with shoulder conditions. It consists of 13 items divided into two subscales: Pain subscale (5 items) - assesses severity of shoulder pain during specific activities Disability subscale (8 items) - assesses difficulty in performing functional tasks such as dressing, reaching, lifting, and carrying objects Each item is scored on a Visual Analog Scale (0-10), where higher scores indicate greater pain and disability. The total SPADI score is calculated as a percentage, with 0% representing no disability and 100% representing maximum disability.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2026.
- Background: PubMed 30285401Varacallo MA, El Bitar Y, Sina RE, Mair SD. Rotator Cuff Syndrome. 2024 Mar 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK531506/
- BackgroundKuhn JE. Prevalence, natural history, and nonoperative treatment of rotator cuff disease. Operative techniques in sports medicine. 2023;31(1):150978.
- Background: PubMed 34148475Meyers AR, Wurzelbacher SJ, Krieg EF, Ramsey JG, Crombie K, Christianson AL, Luo L, Burt S. Work-Related Risk Factors for Rotator Cuff Syndrome in a Prospective Study of Manufacturing and Healthcare Workers. Hum Factors. 2023 May;65(3):419-434. doi: 10.1177/00187208211022122. Epub 2021 Jun 20.
- BackgroundZahra T, Altaf F, Akhtar H, Awan SS, Sher UA, Waris S. Sleep Quality and Nocturnal Pain in Patients of Rotator Cuff Syndrome. Pakistan Journal of Medical & Health Sciences. 2022;16(09):394-.
- Background: PubMed 34276924Kwan CK, Ko MC, Fu SC, Leong HT, Ling SK, Oh JH, Yung PS. Are muscle weakness and stiffness risk factors of the development of rotator cuff tendinopathy in overhead athletes: a systematic review. Ther Adv Chronic Dis. 2021 Jul 3;12:20406223211026178. doi: 10.1177/20406223211026178. eCollection 2021.
- Background: PubMed 40511351Sidiropoulos K, Samundeeswari S, Giannatos V, Kotsapas M, Arrigoni P, Montoya F, Brilakis E, Latz D, Koukos C. Partial Cuff Repair in Rotator Cuff Tears: Current Concepts and Clinical Considerations. Indian J Orthop. 2025 Feb 4;59(6):743-755. doi: 10.1007/s43465-025-01338-0. eCollection 2025 Jun.
- Background: PubMed 34089878Zhao J, Luo M, Pan J, Liang G, Feng W, Zeng L, Yang W, Liu J. Risk factors affecting rotator cuff retear after arthroscopic repair: a meta-analysis and systematic review. J Shoulder Elbow Surg. 2021 Nov;30(11):2660-2670. doi: 10.1016/j.jse.2021.05.010. Epub 2021 Jun 2.
- Background: PubMed 35257948Giri A, O'Hanlon D, Jain NB. Risk factors for rotator cuff disease: A systematic review and meta-analysis of diabetes, hypertension, and hyperlipidemia. Ann Phys Rehabil Med. 2023 Feb;66(1):101631. doi: 10.1016/j.rehab.2022.101631. Epub 2022 Nov 30.
- Background: PubMed 39966503Khadour FA, Khadour YA, Alharbi NSK, Alhatem W, Albarroush D, Dao X. Risk factors for rotator cuff tear in Syrian adults: a cross-sectional study. Sci Rep. 2025 Feb 18;15(1):5837. doi: 10.1038/s41598-025-89878-1.
- Background: PubMed 29494017Javed O, Maldonado KA, Ashmyan R. Anatomy, Shoulder and Upper Limb, Muscles. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK482410/
- Background: PubMed 37875953Cao Z, Li Q, Li Y, Wu J. The association of metabolic syndrome with rotator cuff tendinopathy: a two-sample Mendelian randomization study. Diabetol Metab Syndr. 2023 Oct 24;15(1):211. doi: 10.1186/s13098-023-01189-5.
- Individual participant dataSharing planned: No
Related trials for Rotator Cuff Syndrome
Not yet recruiting
The Effectiveness of High-intensity Laser Therapy in Femoroacetabular Impingement Syndrome
Femoroacetabular Impingement Syndrome, Femoro-acetabular Impingement
Not yet recruiting
TECAR With Shoulder Chronic Shoulder Impingement Syndrome
Shoulder Impingement Syndrome
Recruiting
Device-Assisted Balance Training for People With Shoulder Impingement
Shoulder
Not yet recruiting
"Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial Pain"
Subacromial Impingement Syndrome
Active, not recruiting
Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?
Femoroacetabular Impingement Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Iqra Nazir, MSPT* principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Myofascial Trigger Point Release (MFTR)+ conservative physiotherapy Group and Neil Asher Technique (NAT) + conservative physiotherapy Group in people with Rotator Cuff Syndrome, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Samrood Akram, PhD* (03324806143, samrood.akram@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Numeric Pain Rating Scale (NPRS) - Pain Assessment (time frame: upto 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07645963, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.